Literature DB >> 6806937

HLA-DR phenotype and HLA-B,DR haplotype frequencies in 704 unrelated Danes.

B K Jakobsen, N Morling, P Platz, L P Ryder, M Thomsen, A Svejgaard.   

Abstract

HLA-ABC and DR antigens were studied in 704 unrelated Danes (84 cadaver kidney donors, 307 healthy individuals, and 313 uremic patients), HLA-DR1, 2, 3, 4, 7, w8, and w10 were investigated in all individuals, whereas DR5, "DRw6", and w9 were only studied in parts of the material. The frequencies of DR1, 2, 3, 4, 5, and w10 were similar in the three groups, while those of "DRw6", DR7 and w8 differed significantly. The deviation of the DR7 frequency was small and probably due to change; "DRw6" is considered difficult to define, and DRw8 may have been difficult to define in the early part of the material. DR-phenotype distributions showed perfect fits to Hardy-Weinberg expectations for the three groups separately and for the combined group. When our combined DR antigen frequencies were compared with those from another Danish sample (Madsen et al, 1981), significant differences were found for "DRw6", w8 and w10. However, in general, the same HLA-B,DR phenotype combinations showed significant positive associations in the two samples, and most of the corresponding haplotype frequencies and delta values were quite similar.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6806937     DOI: 10.1111/j.1399-0039.1981.tb01391.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  7 in total

1.  HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment.

Authors:  H Bliddal; B Eiberg; P Helin; A Svejgaard
Journal:  Ann Rheum Dis       Date:  1989-07       Impact factor: 19.103

2.  Treatment failures in patients with type 2 (non-insulin-dependent) diabetes.

Authors:  L Groop; P H Groop; S Koskimies
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

3.  Restriction fragment length polymorphism of the HLA-DP subregion and correlations to HLA-DP phenotypes.

Authors:  J J Hyldig-Nielsen; N Morling; N Odum; L P Ryder; P Platz; B Jakobsen; A Svejgaard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

4.  Relationship between B-cell function and HLA antigens in patients with type 2 (non-insulin-dependent) diabetes.

Authors:  L Groop; P H Groop; S Koskimies
Journal:  Diabetologia       Date:  1986-11       Impact factor: 10.122

5.  DNA polymorphism of HLA class II genes in primary biliary cirrhosis.

Authors:  N Morling; K Dalhoff; L Fugger; J Georgsen; B Jakobsen; L Ranek; N Odum; A Svejgaard
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

6.  Influence of previous gold treatment and other patient variables on outcome of treatment with disease modifying anti-rheumatic drugs (DMARD) in patients with rheumatoid arthritis.

Authors:  M W Bentzon; I Gad; P Halberg; O Halskov; B K Jacobsen; I Lorenzen; N Morling; A Svejgaard
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

7.  The distribution of HLA DQ2 and DQ8 haplotypes and their association with health indicators in a general Danish population.

Authors:  Line Lund Kårhus; Betina H Thuesen; Tea Skaaby; Jüri J Rumessen; Allan Linneberg
Journal:  United European Gastroenterol J       Date:  2018-03-08       Impact factor: 4.623

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.